Safety of Front-Line R-Mini-CHOP with or without Acalabrutinib in Older Adults with DLBCL - an Interim Analysis of Serious Adverse Events in the Arched / GLA 2022-1 Randomized, Open-Label, Phase 3 Trial
Konstantinos Christofyllakis(Saarland University), Mathias Rummel(Universitätsklinikum Gießen und Marburg), Igor Age Kos(Saarland University), Kai Wille(Johannes Wesling Klinikum Minden), D. Hellwig(Universitätsklinikum des Saarlandes), Niklas Gebauer(University Hospital Schleswig-Holstein), Börge Arndt(Helios Klinikum Emil von Behring), Christian Buske(University Hospital Ulm), Julian Topaly(Heidelberg University), Viola Poeschel(Saarland University), Octavian Fleser(Saarland University), Markus Loeffler(Leipzig University), Boris Kubuschock, Florian Zettl(Universitätsmedizin Göttingen), Georg Lenz(Charité - Universitätsmedizin Berlin), Pascal Blatt(Saarland University), Manfred Ahlgrimm(Saarland University), Rolf Mahlberg(Klinikum Mutterhaus der Borromäerinnen), Martin Dreyling(LMU Klinikum), Heinz Kirchen(Krankenhaus der Barmherzigen Brüder Trier), Andreas Rosenwald, Bettina Altmann(Leipzig University), Volkmar Boehme(Asklepios Klinik St. Georg), Dominic Kaddu‐Mulindwa(Saarland University), Chrysoula Doxani(University of Thessaly), Vadim Lesan(Saarland University), Florian Scherer(German Cancer Research Center), Stephanie Maurer(Saarland University), Ralf Ulrich Trappe(Evangelisches Diakoniekrankenhaus), Andreas Viardot(University Hospital Ulm), Theodoros P. Vassilakopoulos(National and Kapodistrian University of Athens), Roland Schmitz(World Wide Web Consortium), Bjoern Chapuy(University of Göttingen), German Ott(Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology), Nina Rosa Neuendorff(Universitätsklinik Marien Hospital Herne), Alexander Bott(Nuremberg Hospital), Maike Nickelsen, Sarah Altmeyer(Saarland University), Reiner Siebert(Universität Ulm), Bertram Glass(Asklepios Klinik St. Georg), Jörg-Thomas Bittenbring(Saarland University), Gerhard Held(Saarland University), Susanne Schmidt(Saarland University), Zanir Abdi(Saarland University), Martin Bentz(Städtisches Klinikum Karlsruhe), Matthias Müeller(Medical University of Vienna), Tobias Gaska(Brüderkrankenhaus St. Josef Paderborn), Hanno M. Witte(Bundeswehrkrankenhaus), Oguzhan Nakisli(Saarland University), Norbert Schmitz(University Hospital Münster)
Cited by 0
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k